139 related articles for article (PubMed ID: 35612433)
1. Low-Dose Olanzapine in the Treatment of Adolescents with Anorexia Nervosa: An Observational Naturalistic Case-Control Study.
Pruccoli J; Pettenuzzo I; Parmeggiani A
J Child Adolesc Psychopharmacol; 2022 Jun; 32(5):304-310. PubMed ID: 35612433
[No Abstract] [Full Text] [Related]
2. General psychopathological symptoms in children, adolescents, and young adults with anorexia nervosa-a naturalistic study on follow-up and treatment.
Pruccoli J; Chiavarino F; Nanni C; Parmeggiani A
Eur J Pediatr; 2023 Mar; 182(3):997-1007. PubMed ID: 36542163
[TBL] [Abstract][Full Text] [Related]
3. The role of risperidone in the treatment of children and adolescents with anorexia nervosa.
Pruccoli J; Bergonzini L; Pettenuzzo I; Parmeggiani A
J Psychopharmacol; 2023 Jun; 37(6):545-553. PubMed ID: 37345750
[TBL] [Abstract][Full Text] [Related]
4. Early onset anorexia nervosa: Multidisciplinary hospital intervention in a 1-year follow-up study.
Pruccoli J; Parmeggiani A
Early Interv Psychiatry; 2023 Oct; 17(10):992-1000. PubMed ID: 36794654
[TBL] [Abstract][Full Text] [Related]
5. Treatment response in children and adolescents with anorexia nervosa: a naturalistic, case-control study.
Pruccoli J; Pettenuzzo I; Parmeggiani A
Eat Weight Disord; 2022 Oct; 27(7):2879-2887. PubMed ID: 35704179
[TBL] [Abstract][Full Text] [Related]
6. Olanzapine use for the adjunctive treatment of adolescents with anorexia nervosa.
Norris ML; Spettigue W; Buchholz A; Henderson KA; Gomez R; Maras D; Gaboury I; Ni A
J Child Adolesc Psychopharmacol; 2011 Jun; 21(3):213-20. PubMed ID: 21510781
[TBL] [Abstract][Full Text] [Related]
7. Premenarchal anorexia nervosa: clinical features, psychopharmacological interventions, and rehospitalization analysis in a 1-year follow-up, controlled study.
Pruccoli J; Pugliano R; Pranzetti B; Parmeggiani A
Eur J Pediatr; 2023 Jun; 182(6):2855-2864. PubMed ID: 37052674
[TBL] [Abstract][Full Text] [Related]
8. The Role of Mood Stabilizers in Children and Adolescents with Anorexia Nervosa: A 1-year Follow-Up, Propensity Score-Matched Study.
Pruccoli J; Parmeggiani A
Pharmacopsychiatry; 2023 May; 56(3):118-125. PubMed ID: 37187178
[TBL] [Abstract][Full Text] [Related]
9. Antipsychotic effects on anthropometric outcomes in anorexia nervosa: a retrospective chart review of hospitalized children and adolescents.
Frank B; Arnold S; Jaite C; Correll CU
J Eat Disord; 2023 Sep; 11(1):151. PubMed ID: 37674209
[TBL] [Abstract][Full Text] [Related]
10. [Prescription of olanzapine in children and adolescent psychiatric patients].
Frémaux T; Reymann JM; Chevreuil C; Bentué-Ferrer D
Encephale; 2007; 33(2):188-96. PubMed ID: 17675914
[TBL] [Abstract][Full Text] [Related]
11. An open trial of olanzapine in anorexia nervosa.
Barbarich NC; McConaha CW; Gaskill J; La Via M; Frank GK; Achenbach S; Plotnicov KH; Kaye WH
J Clin Psychiatry; 2004 Nov; 65(11):1480-2. PubMed ID: 15554759
[TBL] [Abstract][Full Text] [Related]
12. Low-dose olanzapine monotherapy in girls with anorexia nervosa, restricting subtype: focus on hyperactivity.
Leggero C; Masi G; Brunori E; Calderoni S; Carissimo R; Maestro S; Muratori F
J Child Adolesc Psychopharmacol; 2010 Apr; 20(2):127-33. PubMed ID: 20415608
[TBL] [Abstract][Full Text] [Related]
13. Olanzapine in the treatment of low body weight and obsessive thinking in women with anorexia nervosa: a randomized, double-blind, placebo-controlled trial.
Bissada H; Tasca GA; Barber AM; Bradwejn J
Am J Psychiatry; 2008 Oct; 165(10):1281-8. PubMed ID: 18558642
[TBL] [Abstract][Full Text] [Related]
14. Atypical antipsychotics in severe anorexia nervosa in children and adolescents--review and case reports.
Mehler-Wex C; Romanos M; Kirchheiner J; Schulze UM
Eur Eat Disord Rev; 2008 Mar; 16(2):100-8. PubMed ID: 18000964
[TBL] [Abstract][Full Text] [Related]
15. Refeeding syndrome and psychopharmacological interventions in children and adolescents with Anorexia Nervosa: a focus on olanzapine-related modifications of electrolyte balance.
Pruccoli J; Barbieri E; Visconti C; Pranzetti B; Pettenuzzo I; Moscano F; Malaspina E; Marino M; Valeriani B; Parmeggiani A
Eur J Pediatr; 2024 Apr; 183(4):1935-1941. PubMed ID: 38347260
[TBL] [Abstract][Full Text] [Related]
16. A placebo-controlled pilot study of adjunctive olanzapine for adolescents with anorexia nervosa.
Kafantaris V; Leigh E; Hertz S; Berest A; Schebendach J; Sterling WM; Saito E; Sunday S; Higdon C; Golden NH; Malhotra AK
J Child Adolesc Psychopharmacol; 2011 Jun; 21(3):207-12. PubMed ID: 21663423
[TBL] [Abstract][Full Text] [Related]
17. Psychotropic drug treatment in anorexia nervosa. Search for differences in efficacy/tolerability between adolescent and mixed-age population.
Balestrieri M; Oriani MG; Simoncini A; Bellantuono C
Eur Eat Disord Rev; 2013 Sep; 21(5):361-73. PubMed ID: 23733453
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the efficacy and safety of olanzapine as an adjunctive treatment for anorexia nervosa in adolescent females: a randomized, double-blind, placebo-controlled trial.
Spettigue W; Buchholz A; Henderson K; Feder S; Moher D; Kourad K; Gaboury I; Norris M; Ledoux S
BMC Pediatr; 2008 Jan; 8():4. PubMed ID: 18234120
[TBL] [Abstract][Full Text] [Related]
19. Olanzapine therapy in anorexia nervosa: psychobiological effects.
Brambilla F; Garcia CS; Fassino S; Daga GA; Favaro A; Santonastaso P; Ramaciotti C; Bondi E; Mellado C; Borriello R; Monteleone P
Int Clin Psychopharmacol; 2007 Jul; 22(4):197-204. PubMed ID: 17519642
[TBL] [Abstract][Full Text] [Related]
20. The role of olanzapine in the treatment of anorexia nervosa.
Dunican KC; DelDotto D
Ann Pharmacother; 2007 Jan; 41(1):111-5. PubMed ID: 17190846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
